Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Back to Press-Releases

DIA Announces New Board of Directors at 2023 Global Annual Meeting

Acknowledging our exceptional Board of Directors, both incoming and outgoing

Washington D.C. – June 26, 2023. Today, at the DIA (Drug Information Association) Global Annual Meeting in Boston, MA, the organization welcomed fresh faces to their multidisciplinary Board of Directors and expressed gratitude to the outgoing Directors for their many contributions.

“DIA 2023 Global Annual Meeting, being held this week in Boston, includes over 5,000 patients, professionals, organizations, passionate students and government representatives from across the international life science communities, all working together to illuminate the path to the best healthcare outcomes worldwide.” says Marwan Fathallah, President, and GCE, DIA.  “This meeting is the perfect venue to introduce our newly appointed DIA Board of Directors, with each member having specific and extensive industry experience, I am confident they will help us strategize the most successful pathways to the future of healthcare. I want to personally acknowledge our outgoing members; DIA will be forever grateful for their hard work and dedication.” 

DIA 2023-2024 Board of Directors

*New Members

  • Michael Rosenblatt, MD Chair
  • Kihito Takahashi, MD, PhD Chair-elect
  • Cynthia Verst, PharmD, MS Past Chair
  • Marwan Fathallah, MBA, DIA President & GCE
  • Junaid Bajwa, MD Director
  • Jens Grueger, PhD Director*
  • Peter Honig, MD, MPH Director
  • Frank Jiang, MD, PhD Director
  • Tatyana Kosheleva, CPA, Director
  • Jason Monteleone, CPA, MBA Director
  • Chockalingam Palaniappan, PhD* Director
  • Peter Sorger, PhD Director
  • Peter Ronco, Director*
  • Rachel Zhang, MBA Director
  • Craig Cara, CPA Board Observer*
  • Wendy Yan, MBA Board Observer*

DIA thanks the incredible work of these exiting Directors:

  • Michael Romano, CPA
  • Judith Ng-Cashin, MD
  • Michael Devoy, MD
  • Karin Van Baelen


While maintaining neutral, transparent, and collaborative engagement, DIA’s Board of Directors volunteer to provide strategic clarity, direction, and policy objectives to offer all stakeholders opportunities to co-create, problem-solve, and illuminate cohesive pathways to the future of global and regional life sciences developments.

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.